{
  "sample_declaration": "Fictional and representative campaign input; not production claims or brand content.",
  "campaign_brief": {
    "campaign_name": "Asteron Evidence Conversation (fictional)",
    "country": "US",
    "policy_jurisdiction": "FDA",
    "mode": "promotional",
    "brand": "ASTERON (fictional)",
    "indication": "Fictional approved indication",
    "target_segment": "Oncologists",
    "behavioral_objective": "Review the fictional approved evidence",
    "desired_kpi": ["qualified-review-readiness"],
    "call_to_action": "Review the fictional evidence",
    "channels": ["email"]
  },
  "approved_claims": [
    {
      "claim_id": "fictional-c-001",
      "text": "FICTIONAL CLAIM: In the simulated study, the prespecified endpoint was met.",
      "category": "efficacy",
      "source_document": "Asteron Fictional Approved Messages",
      "source_reference": "Simulated Study, Table 1",
      "expiry": null,
      "restrictions": "Demonstration only; never use in operational materials."
    },
    {
      "claim_id": "fictional-c-002",
      "text": "FICTIONAL SAFETY: Consult the simulated prescribing information for the complete safety profile.",
      "category": "safety",
      "source_document": "Asteron Fictional Approved Messages",
      "source_reference": "Simulated Safety Section",
      "expiry": null,
      "restrictions": "Demonstration only; never use in operational materials."
    }
  ],
  "required_safety_content": ["fictional-c-002"]
}